127 related articles for article (PubMed ID: 37811666)
1. Deep Learning-Based T2-Weighted MR Image Quality Assessment and Its Impact on Prostate Cancer Detection Rates.
Lin Y; Belue MJ; Yilmaz EC; Harmon SA; An J; Law YM; Hazen L; Garcia C; Merriman KM; Phelps TE; Lay NS; Toubaji A; Merino MJ; Wood BJ; Gurram S; Choyke PL; Pinto PA; Turkbey B
J Magn Reson Imaging; 2024 Jun; 59(6):2215-2223. PubMed ID: 37811666
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate.
Liu Y; Wang S; Xu G; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
J Magn Reson Imaging; 2023 Sep; 58(3):709-717. PubMed ID: 36773016
[TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
Gaur S; Harmon S; Mehralivand S; Bednarova S; Calio BP; Sugano D; Sidana A; Merino MJ; Pinto PA; Wood BJ; Shih JH; Choyke PL; Turkbey B
J Magn Reson Imaging; 2018 Nov; 48(5):1326-1335. PubMed ID: 29603833
[TBL] [Abstract][Full Text] [Related]
4. Deep-Learning-Based Artificial Intelligence for PI-RADS Classification to Assist Multiparametric Prostate MRI Interpretation: A Development Study.
Sanford T; Harmon SA; Turkbey EB; Kesani D; Tuncer S; Madariaga M; Yang C; Sackett J; Mehralivand S; Yan P; Xu S; Wood BJ; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2020 Nov; 52(5):1499-1507. PubMed ID: 32478955
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
[TBL] [Abstract][Full Text] [Related]
6. Predictors of prostate cancer detection in MRI PI-RADS 3 lesions - Reality of a tertiary center.
Araújo D; Gromicho A; Dias J; Bastos S; Maciel RM; Sabença A; Xambre L
Arch Ital Urol Androl; 2023 Dec; 95(4):11830. PubMed ID: 38117217
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the relationship between PI-RADS scores and the pathological results of targeted biopsy based on MRI].
Wang YM; Shang JW; Dong L; Liang LH; Zhao RZ; Liang C; Wang SQ; Xia W; Cheng G; Hua LX
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):942-947. PubMed ID: 37968079
[No Abstract] [Full Text] [Related]
8. A Cascaded Deep Learning-Based Artificial Intelligence Algorithm for Automated Lesion Detection and Classification on Biparametric Prostate Magnetic Resonance Imaging.
Mehralivand S; Yang D; Harmon SA; Xu D; Xu Z; Roth H; Masoudi S; Sanford TH; Kesani D; Lay NS; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Acad Radiol; 2022 Aug; 29(8):1159-1168. PubMed ID: 34598869
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
[TBL] [Abstract][Full Text] [Related]
10. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
12. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
[TBL] [Abstract][Full Text] [Related]
13. Deep-Learning Models for Detection and Localization of Visible Clinically Significant Prostate Cancer on Multi-Parametric MRI.
Sun Z; Wu P; Cui Y; Liu X; Wang K; Gao G; Wang H; Zhang X; Wang X
J Magn Reson Imaging; 2023 Oct; 58(4):1067-1081. PubMed ID: 36825823
[TBL] [Abstract][Full Text] [Related]
14. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
[TBL] [Abstract][Full Text] [Related]
15. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
Kuhl CK; Bruhn R; Krämer N; Nebelung S; Heidenreich A; Schrading S
Radiology; 2017 Nov; 285(2):493-505. PubMed ID: 28727544
[TBL] [Abstract][Full Text] [Related]
16. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
Costa DN; Jia L; Subramanian N; Xi Y; Rofsky NM; Recchimuzzi DZ; de Leon AD; Arraj P; Pedrosa I
AJR Am J Roentgenol; 2021 Aug; 217(2):395-403. PubMed ID: 32876473
[No Abstract] [Full Text] [Related]
17. Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.
Hansen NL; Kesch C; Barrett T; Koo B; Radtke JP; Bonekamp D; Schlemmer HP; Warren AY; Wieczorek K; Hohenfellner M; Kastner C; Hadaschik B
BJU Int; 2017 Nov; 120(5):631-638. PubMed ID: 27862869
[TBL] [Abstract][Full Text] [Related]
18. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.
Schelb P; Kohl S; Radtke JP; Wiesenfarth M; Kickingereder P; Bickelhaupt S; Kuder TA; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
Radiology; 2019 Dec; 293(3):607-617. PubMed ID: 31592731
[TBL] [Abstract][Full Text] [Related]
19. Value of Dynamic Contrast-Enhanced (DCE) MR Imaging in Peripheral Lesions in PI-RADS-4 Patients.
Ullrich T; Quentin M; Arsov C; Laqua N; Abrar D; Hiester A; Albers P; Antoch G; Schimmöller L
Rofo; 2020 May; 192(5):441-447. PubMed ID: 31622990
[TBL] [Abstract][Full Text] [Related]
20. Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers.
Yilmaz EC; Shih JH; Belue MJ; Harmon SA; Phelps TE; Garcia C; Hazen LA; Toubaji A; Merino MJ; Gurram S; Choyke PL; Wood BJ; Pinto PA; Turkbey B
Radiology; 2023 May; 307(4):e221309. PubMed ID: 37129493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
